ZoomMed Enters Into an Exclusive Agreement to Market and Implement the Medical Interactive Communication Platform "CESAMSPHERE"
(firmenpresse) - MONTREAL, QUEBEC -- (Marketwire) -- 11/22/11 -- ZoomMed Inc. (TSX: ZMD), is pleased to announce it has entered into an exclusive agreement to market and implement "CESAMSPHERE" a secured medical interactive communication platform developed by "Centre d'Expertises et de Services pour l'Avancement Medical Inc. (CESAM)".
The concluded agreement with CESAM will provide the addition of new functionalities to the ZRx Prescriber, such as medical tele-expertise, continuing medical education and laboratory diagnostic tests analysis by specialists, strengthening the bridge between physicians, pharmacists and the other stakeholders in the healthcare community.
"I am convinced that including this platform to our product offering will significantly contribute to facilitate the healthcare professional's tasks, now allowing, via the ZRx Prescriber, interactive communication between specialists, general practitioners, and pharmacists" says M. Yves Marmet, President and CEO of ZoomMed.
"Furthermore, this Web-platform, which was developed, particularly, to operate on wireless devices and smart phones identical to ZoomMed's, includes many applications which raise strong interest not only from the healthcare community and particularly pharmaceutical corporations, but to major telecommunication corporations", concluded M. Marmet.
About CESAMSPHERE
The tele-expertise application allows to, via the ZRx Prescriber, receive medical advices, offer support services related to prescription drugs, avoid unnecessary hospitalizations, enhance patient's therapeutic treatment, and promote delivery of community care.
Continued medical education is an application which allows, via the ZRx Prescriber, healthcare industry's educational program development by putting in place mentoring program throughout Canada and the United States.
Moreover, laboratory diagnostic tests analysis by specialists provide physicians and pharmacists with the ability to send personalized preventive medical consultation requests.
For further information on CESAMSPHERE, visit the following Web Site:
About ZoomMed
ZoomMed developed the ZRx Prescriber, a technological innovative Web application that enables physicians to use a wireless device, such as the IPod Touch™, IPhone™, IPad™, Google Android™, other PDA's or computers, to write and rapidly deliver scripts. The ZRx Prescriber is quick, efficient and intuitive. Since it is a stand-alone product, it can easily be integrated to any Electronic Medical Record application (EMR). Furthermore, ZoomMed also offers "PraxisLab" a new application that enhances all aspects of the prescription filling process and the complete pharmacists patient file management. PraxisLab uses state-of-the-art protocols and up-to-date software standards, allowing high compatibility with existing software, as well as new generation software.
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Contacts:
ZoomMed
Mr. Yves Marmet
President and Chief Executive Officer
(450) 678-5457, ext 228
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 22.11.2011 - 14:18 Uhr
Sprache: Deutsch
News-ID 90177
Anzahl Zeichen: 0
contact information:
Town:
MONTREAL, QUEBEC
Kategorie:
Medical Devices
Diese Pressemitteilung wurde bisher 247 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"ZoomMed Enters Into an Exclusive Agreement to Market and Implement the Medical Interactive Communication Platform "CESAMSPHERE""
steht unter der journalistisch-redaktionellen Verantwortung von
ZoomMed inc. (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
